Overview
Julie Gold is an Oncologist and a Hematologist in Mount Kisco, New York. Dr. Gold and is rated as an Advanced provider by MediFind in the treatment of Virilizing Ovarian Tumor. Her top areas of expertise are Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Small Cell Lung Cancer (SCLC).
Insurance
Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.
Accepted insurance plans
- Humana
Locations
90 S Bedford Rd, Mount Kisco, NY 10549
400 E Main St, Suite 761, Mount Kisco, NY 10549
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
MediFind cannot find any recent clinical research or clinical trials for Dr. Julie M. Gold
Msk Harrison
Rachel Grisham is an Oncologist in West Harrison, New York. Dr. Grisham and is rated as an Elite provider by MediFind in the treatment of Virilizing Ovarian Tumor. Her top areas of expertise are Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Liver Embolization, and Salpingo-Oophorectomy.
Stuart Lichtman is an Oncologist and a Hematologist in Commack, New York. Dr. Lichtman and is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, and Virilizing Ovarian Tumor.
Barnabas Health Medical Group PC
Jennifer Wagmiller is an Oncologist and a Hematologist in Livingston, New Jersey. Dr. Wagmiller and is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. Her top areas of expertise are Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, Breast Cancer, and Paget Disease of the Breast. Dr. Wagmiller is currently accepting new patients.
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Distinguished
- Angiosarcoma
- Inflammatory Breast Cancer
- Paget Disease of the Breast
- Pleuropulmonary Blastoma
- Small Cell Lung Cancer (SCLC)
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Anemia
- Breast Cancer
- EGFR Positive Lung Cancer
- Endometrial Cancer
- HER-2 Positive Breast Cancer
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)
- Agranulocytosis
- Aplastic Anemia
- Bladder Cancer